ONCT

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Oncternal Therapeutics (ONCT) Ownership - Who owns Oncternal Therapeutics?

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

12230 El Camino Real

Phone

+1 858 434-1113

Employees

Web

https://www.oncternal.com

Details

Group

Domestic Stock Funds

Fundamentals

ONCT

Capitalization

1.56M

P/E Ratio

N/A

Risk (Beta)

1.10

Dividend Yield

N/A

Total Cash

N/A

Total Cash/Share

N/A

Total Debt

278K

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

N/A

ROE

N/A

Book Value

22.9M

P/B Ratio

0.17

Cash Flow

N/A

Earnings

N/A

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

Current Ratio

4.66

Current Revenue Per Employee

18211.11

Dividends Per Share - Security

N/A

EBITDA

N/A

Float

N/A

Float - Current

N/A

Gross Income Margin

85.05

Revenue To Assets

N/A

Shares Held By Institutions

3.71M

Shares Outstanding - Current

2.96M

Total Liabilities

6.22M

Total Volume MTD

N/A

Value

Gain YTD

-95.090

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need.

Industry Biotechnology